Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haoran Nie

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bioorganic Chemistry|June 11, 2023
Discovery of potent and effective inhibitors containing sulfoxide structures targeting EML4-ALK rearrangement and EGFR mutant non-small cell lung cancerBaijiao An, Yangyang Fan, Wei Li, et al.
Drug Design, Development and Therapy|March 4, 2025
Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFR<sup>C797S</sup> Mutation in Non-Small Cell Lung CancerMengxuan Wang, Zhenhong Xia, Wenyan Nie, et al.
Bioorganic Chemistry|March 30, 2024
The new N<sup>2</sup>, N<sup>4</sup>-diphenylpyridine-2,4-diamine deuterated derivatives as EGFR inhibitors to overcome C797S-mediated resistanceJiadai Liu, Wenyan Nie, Haoran Nie, et al.
Cell Death & Disease|November 9, 2023
A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferationBaijiao An, Wenyan Nie, Jinhui Hu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bioorganic Chemistry|June 11, 2023
Discovery of potent and effective inhibitors containing sulfoxide structures targeting EML4-ALK rearrangement and EGFR mutant non-small cell lung cancerBaijiao An, Yangyang Fan, Wei Li, et al.
Drug Design, Development and Therapy|March 4, 2025
Design, Synthesis and Evaluation of Novel Cyclopropanesulfonamide Derivatives for the Treatment of EGFR<sup>C797S</sup> Mutation in Non-Small Cell Lung CancerMengxuan Wang, Zhenhong Xia, Wenyan Nie, et al.
Bioorganic Chemistry|March 30, 2024
The new N<sup>2</sup>, N<sup>4</sup>-diphenylpyridine-2,4-diamine deuterated derivatives as EGFR inhibitors to overcome C797S-mediated resistanceJiadai Liu, Wenyan Nie, Haoran Nie, et al.
Cell Death & Disease|November 9, 2023
A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferationBaijiao An, Wenyan Nie, Jinhui Hu, et al.
Pageof 2